22.26
Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
The Rhesus Antigen and Blood Grou…
The Rhesus or Rh antigen is a class of agglutinogen on the red blood cells or RBCs. Its presence or absence categorizes a person as Rh-positive or Rh-negative.
When reporting a person's blood group, the Rh antigen is typically combined with the A and B antigens.
For instance, the blood type of a person with antigens A and Rh is designated as A-positive. Conversely, in the absence of Rh antigen, the person's blood is referred to as A-negative.
Unlike the ABO system, the plasma does not naturally contain anti-Rh antibodies.
So, exposure to the Rh antigen can trigger an immune response in Rh-negative individuals, leading to hemolysis.
For example, suppose an Rh-negative mother carries an Rh-positive fetus. In that case, the mother's immune system recognizes the Rh antigen on the fetal RBCs as foreign, triggering the production of anti-Rh antibodies.
Typically, these antibodies do not interfere in the first pregnancy. However, in subsequent pregnancies with Rh-positive fetuses, the fetal RBCs are at risk of hemolysis due to the existing anti-Rh antibodies in the mother's blood.
View the full transcript and gain access to JoVE Core videos
Q1: What is the Rh antigen and how does it determine blood type?
The Rh antigen is a protein on red blood cell surfaces that classifies blood as Rh-positive or Rh-negative. Its presence or absence is combined with ABO antigens to designate complete blood types, such as A-positive or B-negative. Understanding the Rh factor is essential in transfusion medicine for ensuring blood compatibility.
Q2: Why don't Rh-negative people naturally have anti-Rh antibodies?
Unlike the ABO system, plasma does not naturally contain anti-Rh antibodies. Anti-Rh antibodies develop only after exposure to the Rh antigen, triggering an immune response in Rh-negative individuals. This delayed response is why first transfusions with incompatible Rh blood may not cause immediate problems, but subsequent exposures carry greater risk.
Q3: How does Rh incompatibility affect pregnancy and the fetus?
When an Rh-negative mother carries an Rh-positive fetus, her immune system may recognize fetal Rh antigens as foreign, producing anti-Rh antibodies. In the first pregnancy, these antibodies typically cause no harm. However, in subsequent pregnancies with Rh-positive fetuses, existing antibodies cross the placenta and attack fetal red blood cells, causing hemolysis and hemolytic disease of the newborn.
Q4: What is RhoGAM and how does it prevent hemolytic disease of the newborn?
RhoGAM is a serum containing anti-Rh antibodies administered to Rh-negative mothers during and after delivery of Rh-positive babies. It prevents the mother's immune system from recognizing fetal Rh antigens as foreign, stopping anti-Rh antibody production. This protective measure significantly reduces the risk of hemolytic disease in future pregnancies.
Q5: How is the Rh blood group reported alongside the ABO system?
The Rh antigen status is combined with ABO antigens when reporting blood type. A person with A and Rh antigens is designated A-positive, while someone with A antigens but no Rh antigen is A-negative. This combined classification ensures accurate blood matching for transfusions and identifies potential maternal-fetal incompatibility risks.
Q6: What happens when Rh-negative individuals receive Rh-positive blood?
Exposure to Rh-positive blood triggers an immune response in Rh-negative individuals, leading to anti-Rh antibody production. This can cause hemolysis, the destruction of red blood cells, resulting in transfusion complications. Subsequent transfusions with Rh-positive blood carry increased risk of severe hemolytic reactions due to existing antibodies.
Q7: Why is understanding Rh compatibility critical in transfusion medicine?
Incompatible Rh factors between donor and recipient trigger immune responses causing hemolysis and potential life-threatening complications. Proper Rh typing prevents transfusion reactions and is especially vital for Rh-negative recipients who lack natural anti-Rh antibodies. Accurate Rh classification ensures safe blood matching and protects patient health during transfusions.